← Back to Clinical Trials
Recruiting NCT06487754
NCT06487754 New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06487754 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Grenoble |
| Condition | Transgender Persons |
| Study Type | OBSERVATIONAL |
| Enrollment | 15 participants |
| Start Date | 2024-09-27 |
| Primary Completion | 2025-02 |
Trial Parameters
Condition Transgender Persons
Sponsor University Hospital, Grenoble
Study Type OBSERVATIONAL
Phase N/A
Enrollment 15
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-09-27
Completion 2025-02
All Conditions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This descriptive qualitative study aim to describe the characteristics of pelvic pain in transgender (trans) individuals using testosterone therapy and the impact on their quality of life. This study also aim to understand the levers and obstacles to consulting a health care professional.
Eligibility Criteria
Inclusion Criteria: * Being a trans masculine individual * Taking a gender affirming hormonal therapy (GAHT) * living close to Grenoble * having pelvic pain that appeared or were modified after taking GAHT Exclusion Criteria: * Subject under guardianship or subject deprived of liberty Refusal of voice recording
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology